CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights

CD Genomics, a pioneering leader in genomic solutions, is proud to announce its cutting-edge whole genome sequencing (WGS) services. Utilizing the latest technologies from Illumina and PacBio platforms, CD Genomics offers precise and affordable sequencing solutions for a wide range of organisms, including viruses, microbes, plants, animals, and humans.

Whole genome sequencing represents a significant leap forward in genomic research. By determining the complete DNA sequence of an organism's genome, WGS provides comprehensive insights into chromosomal DNA as well as DNA contained in mitochondria and chloroplasts. This powerful tool supports both de novo sequencing and re-sequencing efforts. De novo sequencing generates the first genome map for a species, while re-sequencing identifies DNA biomarkers such as single nucleotide polymorphisms (SNPs), insertions and deletions (indels), structural variations (SVs), and copy number variations (CNVs) with high accuracy.

The applications of WGS are vast, impacting fields such as disease research, drug discovery, personalized medicine, food safety, agriculture, and pharmacy. Key advantages of WGS include single base-pair resolution, de novo sequencing and genome-wide mutation characterization, population evolution and phylogenetic studies, and its critical role in disease research, drug discovery, and personalized medicine.

CD Genomics combines the strengths of Illumina HiSeq and PacBio systems to deliver fast and accurate WGS and bioinformatics analysis for any species. The company's expert team ensures rigorous quality management at every step, providing confident and unbiased results. The general workflow for WGS includes DNA extraction, library preparation, sequencing, data analysis, and comprehensive reporting.

To ensure the credibility of assembly results, CD Genomics employs several evaluation methods. Parameters such as Contig N50 and Scaffold N50 describe the "completeness" of a genome assembly. EST datasets, RNA sequences, or conserved genes are used to evaluate completeness, while BAC data tests accuracy. For hyper repetitive and heterozygous regions, CD Genomics combines data from HiSeq, PacBio, and Sanger sequencing to ensure precise genome assembly.

CD Genomics is a leading provider of genomic solutions, offering a comprehensive suite of services including whole genome sequencing, bioinformatics analysis, and more. With a commitment to quality and innovation, CD Genomics empowers researchers and clinicians to unlock the secrets of the genome.

CD Genomics' WGS offerings cater to a wide range of applications, including:

1. Human Genetics: Identifying disease-causing mutations and studying complex genetic traits.
2. Cancer Research: Characterizing tumor genomes and discovering novel therapeutic targets.
3. Agricultural Genomics: Improving crop yields and developing disease-resistant plant varieties.
4. Microbial Genomics: Studying pathogen evolution and antibiotic resistance mechanisms.

"Our enhanced WGS services represent a significant leap forward in genomic analysis," says the Chief Scientific Officer at CD Genomics. "By leveraging the latest sequencing technologies and our proprietary bioinformatics pipelines, we're able to deliver highly accurate, deeply covered whole genome data that can uncover critical insights into genetic disorders, cancer genomics, and microbial evolution."

About CD Genomics

CD Genomics is a global provider of genomic services and solutions, offering a wide range of cutting-edge technologies for DNA sequencing, genotyping, and bioinformatics analysis. With a commitment to innovation and scientific excellence, CD Genomics empowers researchers worldwide to unlock the secrets of the genome and drive advancements in medicine, agriculture, and biotechnology.

Contact

Address: Shirley, NY 11967, USA

Email: contact@cd-genomics.com